Mood Stabilizer Therapy and Pravastatin: Higher Risk for Adverse Skin Reactions?

Acta medica (Hradec Kralove) - Czech Republic
doi 10.14712/18059694.2016.101
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Charles University in Prague, Karolinum Press

Related search

Darkness, the New Mood Stabilizer: Inexpensive, Low-Risk, Appreciated by Patients - And Ready for Prime Time

Bipolar Disorders
PsychiatryBiological PsychiatryMental Health
2017English

Pravastatin for the Prevention of Adverse Pregnancy Outcome: Preeclampsia and More?

Journal of Maternal-Fetal and Neonatal Medicine
GynecologyChild HealthPediatricsPerinatologyObstetrics
2016English

Memantine: A New Mood Stabilizer for Treatment-Resistant Bipolar Disorders

2012English

Skin Adverse Events During Dual and Triple Therapy for HCV-Related Cirrhosis

Hepatitis Monthly
HepatologyInfectious Diseases
2014English

Risk Factors for Adverse Reactions From Contrast Agents for Computed Tomography

BMC Medical Informatics and Decision Making
Health PolicyHealth Informatics
2013English

Treatments That Generate Higher Number of Adverse Drug Reactions and Their Symptoms

Ars Pharmaceutica
Pharmaceutical SciencePhilosophy of ScienceHistory
2015English

Idarubicin, Cytarabine and Pravastatin as Induction Therapy for Untreated Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome

Blood
BiochemistryImmunologyCell BiologyHematology
2014English

Screening for Adverse Drug Reactions in Dementia Patients on Cholinesterase Inhibitor Therapy

Journal of the American Geriatrics Society
GerontologyGeriatrics
2019English

Adverse Reactions Associated With Therapeutic Antibiotic Use After Penicillin Skin Testing

Permanente journal,The
Medicine
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy